126 results
8-K
EX-99.1
EQ
Equillium Inc
9 May 24
Equillium Reports First Quarter 2024 Financial Results and Provides Recent Clinical Highlights
4:05pm
, and greater employee compensation expenses, which were partially offset by decreases in certain clinical study expenses and greater estimated Australian
S-8
EX-5.1
l32v8fy1pm7odb7v5f95
25 Mar 24
Registration of securities for employees
4:26pm
S-8
4stla9ydu22iiuyn56
25 Mar 24
Registration of securities for employees
4:26pm
S-8
14kplk6
25 Mar 24
Registration of securities for employees
4:26pm
8-K
EX-99.1
g6r2g7z5sp r91b4
25 Mar 24
Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical Highlights
4:05pm
8-K
EX-99.1
2igp3
8 Mar 24
Departure of Directors or Certain Officers
4:01pm
8-K
EX-99.2
cs9kqx8i71w
8 Nov 23
Equillium Announces Data from Phase 1b EQUALISE Study Presented at the 2023 Annual Meeting of the American Society of Nephrology
4:05pm
8-K
EX-1.1
eoqwv40y95g7 j3k
5 Oct 23
Entry into a Material Definitive Agreement
5:28pm
424B5
5e5fs84vs
5 Oct 23
Prospectus supplement for primary offering
5:23pm
8-K
EX-99.1
xn3e5kl6g pk3eosqez
9 Aug 23
Equillium Reports Second Quarter 2023 Financial Results and Provides Corporate and Clinical Updates
4:06pm